LUMIRADX LTD - *W EXP 09/28/202 (LMDWF)

CUSIP: G5709L117

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / *W EXP 09/28/202
Total 13F shares
7,953,946
Share change
+726
Total reported value
$1,345,325
Price per share
$0.03
Number of holders
12
Value change
+$21
Number of buys
2
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP G5709L117?
CUSIP G5709L117 identifies LMDWF - LUMIRADX LTD - *W EXP 09/28/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) as of Q3 2023

As of 30 Sep 2023, LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,953,946 shares. The largest 10 holders included CVS HEALTH Corp, Senvest Management, LLC, LMR Partners LLP, KIM, LLC, MOORE CAPITAL MANAGEMENT, LP, MMCAP International Inc. SPC, Walleye Capital LLC, WOLVERINE ASSET MANAGEMENT LLC, Walleye Trading LLC, and CAPTRUST FINANCIAL ADVISORS. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.